Literature DB >> 9097378

Pasteurella multocida pneumonia.

N C Klein1, B A Cunha.   

Abstract

Pasteurella multocida, a gram-negative coccobacillus which colonizes the nasopharynx and gastrointestinal tract of many animals, is a well known cause of soft tissue infection after animal bites. Human infection can also occur after non-bite animal exposure, usually via inhalation of contaminated secretions. The respiratory tract is the second most common site of Pasteurella infection after soft tissue infection. Most patients with Pasteurella pulmonary infection are elderly with underlying lung disease, either COPD, bronchiectasis, or malignancy. The spectrum of disease includes pneumonia, tracheobronchitis, lung abscess, and empyema. Clinical features of Pasteurella respiratory tract infections are indistinguishable from other pathogens. A history of cat or dog exposure should alert the clinician to consider Pasteurella as a potential pulmonary pathogen in an elderly patient with chronic lung disease. The preferred drug for the treatment of Pasteurella infections is penicillin. Alternately, doxycycline is highly effective against P multocida.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9097378

Source DB:  PubMed          Journal:  Semin Respir Infect        ISSN: 0882-0546


  24 in total

1.  [A 76-year-old dog owner with fever and dyspnea].

Authors:  M Jüch; J Böttcher-Lorenz; M Gross
Journal:  Internist (Berl)       Date:  2012-09       Impact factor: 0.743

2.  Localization of the intracellular activity domain of Pasteurella multocida toxin to the N terminus.

Authors:  B A Wilson; V G Ponferrada; J E Vallance; M Ho
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 3.  Cellular and molecular action of the mitogenic protein-deamidating toxin from Pasteurella multocida.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  FEBS J       Date:  2011-05-31       Impact factor: 5.542

4.  A Case of Lower Respiratory Tract Infection with Canine-associated Pasteurella canis in a Patient with Chronic Obstructive Pulmonary Disease.

Authors:  Sevitha Bhat; Preetam R Acharya; Dhanashree Biranthabail; Aseem Rangnekar; Sachin Shiragavi
Journal:  J Clin Diagn Res       Date:  2015-08-01

Review 5.  Pasteurella multocida: from zoonosis to cellular microbiology.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

Review 6.  Pasteurella multocida toxin interaction with host cells: entry and cellular effects.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

7.  Rapid and accurate identification of human isolates of Pasteurella and related species by sequencing the sodA gene.

Authors:  Anne-Lise Gautier; Damien Dubois; Françoise Escande; Jean-Loup Avril; Patrick Trieu-Cuot; Olivier Gaillot
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

8.  Taxonomic subgroups of Pasteurella multocida correlate with clinical presentation.

Authors:  Henry I Chen; Kristina Hulten; Jill E Clarridge
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

9.  Fatal fulminant sepsis due to a cat bite in an immunocompromised patient.

Authors:  Ivana Harsanji Drenjancevic; Dubravka Ivic; Domagoj Drenjancevic; Josip Ivic; Boris Pelc; Dubravka Vukovic
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

10.  The Enhancement of the Pasteurella's Bacterin by Propolis Extracts.

Authors:  Tarek Adnan Ahmad; Samar Saeed Rammah; Salah Ahmed Sheweita; Medhat Haroun; Laila Hamdy El-Sayed
Journal:  Rep Biochem Mol Biol       Date:  2018-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.